Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889915 · ClinicalTrials.gov registry record · Phase 4
Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 228
- Enrollment target
NCT00889915 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 228 participants.
The verdict
NCT00889915, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 228 participants
- Enrollment target
Study Summary
This study will determine whether two new psychostimulant medications are more effective, tolerable, and acceptable than two older medications for treating attention deficit hyperactivity disorder.
Interventions
- DRUG Lisdexamfetamine dimesylate
- DRUG Methylphenidate transdermal system
- DRUG Osmotic-release oral system methylphenidate (OROS MPH)
- DRUG Mixed amphetamine salts extended release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00889915
The ClinicalTrials.gov registry entry for NCT00889915 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Lisdexamfetamine dimesylate is the first listed.
NCT00889915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00889915 about?
NCT00889915 is a clinical study titled "Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)". This study will determine whether two new psychostimulant medications are more effective, tolerable, and acceptable than two older medications for treating attention deficit hyperactivity disorder.
What is the current status of trial NCT00889915?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 228 participants. The study started on 2009-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00889915?
The interventions under investigation include: Lisdexamfetamine dimesylate (DRUG), Methylphenidate transdermal system (DRUG), Osmotic-release oral system methylphenidate (OROS MPH) (DRUG), Mixed amphetamine salts extended release (DRUG).
Who is sponsoring clinical trial NCT00889915?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.